Test Price
2,800 AED✅ Home Collection Available
GLUD1 Gene Hyperinsulinemic Hypoglycemia Type 6 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين GLUD1 لنقص سكر الدم بفرط الأنسولين من النوع 6 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – الخلاصة التنفيذية: This genetic test delivers 99.9% diagnostic sensitivity for نقص سكر الدم بفرط الأنسولين (hyperinsulinemic hypoglycemia type 6) via ISO 9001:2015‑accredited NGS processing (Cert: INT/EGQ/2509DA/3139). Clients benefit from hospital‑grade cold‑chain home collection and VIP mobile phlebotomy, with results available in 3‑4 weeks. Post‑test clinical guidance and direct insurance billing verification are seamlessly supported through WhatsApp at +971 54 548 8731. The entire journey is governed by Federal Decree‑Law No. 41 of 2024, CDS Law 2026, and UAE PDPL to guarantee your data privacy and clinical safety.
Clinical Overview and Test Comparator
The GLUD1 Gene Hyperinsulinemic Hypoglycemia Type 6 NGS Test identifies pathogenic variants in the GLUD1 gene that cause congenital hyperinsulinism‑hyperammonemia syndrome. This investigation is critical for differentiating familial forms of persistent hypoglycaemia and guiding targeted dietary or pharmacological intervention.
| Parameter | Our Test (DHA‑Accredited) | Closest Alternative |
|---|---|---|
| Precision | NGS (99.9% analytical sensitivity) | Sanger sequencing (lower throughput) |
| Methodology | Next‑Generation Sequencing (NGS) | Targeted mutation panels |
| Turnaround Time | 3 ‑ 4 Weeks | 4 ‑ 6 Weeks |
Physician Insight & Medication Safety
“As a clinician, I emphasise that a GLUD1 variant report must always be correlated with fasting glucose, ammonia levels, and diazoxide responsiveness. No single gene result defines your child’s metabolic future – it is one piece of a deeply personal diagnostic mosaic. Please never discontinue prescribed diazoxide or octreotide without immediate consultation with your endocrinologist.” – Dr. Prabhakar Reddy (DHA 61713011), Consultant Metabolic Paediatrician.
⚠ Medication Warning
Do not discontinue prescribed medication (especially diazoxide, octreotide, or glucose infusions) without consulting your treating physician. Genetic test results do not substitute for acute clinical management.
Exclusion criteria for home collection: concurrent acute hypoglycaemic crisis (blood glucose < 2.8 mmol/L), haemodynamic instability, or age < 1 week without medical escort. If any of these are present, proceed directly to the nearest emergency department.
Frequently Asked Questions
1. What is the GLUD1 gene test used for?
The GLUD1 gene identifies pathogenic variants causing hyperinsulinemic hypoglycemia type 6, enabling precise diagnosis, family screening, and tailored management with diazoxide or dietary adjustments.
2. هل هذا التحليل ضروري لتحديد العلاج بالنظام الغذائي؟
نعم، يساعد تحليل جين GLUD1 في تأكيد التشخيص الجيني لنقص سكر الدم بفرط الأنسولين من النوع 6، مما يُوجّه العلاج الدقيق باستخدام الديازوكسيد أو النظام الغذائي منخفض البروتين.
3. How is my genetic data protected under UAE law?
All genetic data is processed in full compliance with UAE PDPL and Federal Decree‑Law No. 41 of 2024, Art. 87. Your information is stored on encrypted servers within the UAE, and you retain full rights to data erasure.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians